Actinium Pharmaceuticals, Inc. (ATNM)

Other Income/Expenses (Net)

$336.00K

Quarterly · Period ending: · USD

ATNM logo

ATNM Other Income/Expenses (Net)

Latest reported$336.00K
ATNM Quarterly Other Income/Expenses (Net) ($10.03K → $336.00K)
High-resolution chart · PNG

ATNM other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
336,000
381,000
474,000
561,000
625,000
700,000
853,000
1,033,000
1,065,000
927,000
1,019,000
1,075,000
461,000
547,000
644,000
325,000
83,000
35,000
38,000
46,000
54,000
52,000
55,000
73,000
37,000
13,000
31,040
53,054
59,082
28,909
43,810
49,177
50,030
39,418
43,790
372,166
149,592
-256,000
131,125
502,112
293,779
1,599,000
-1,621,000
693,620
-59,221
4,791,000
1,447,000
967,887
7,940,000
-12,561,000
-4,396,000
188,049
-1,308,000
1,334,000
-410,000
-613,000
-723,000
-1,212
1,481
2,430
3,361
-1,325
-466
-1,555
34,166
-1,759
-1,693
0
0
-1,435
6,316
2,094
0
9,705
4,500
4,653
2,840
0
7,504
10,030
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.